Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Roche's Alecensa topples Pfizer's Xalkori in Asian patients with ALK+ advanced lung cancer

pharmafileOctober 25, 2018

Tag: Roche , immunotherapy , lung cancer

PharmaSources Customer Service